Raphael Townshend
Also known as Raphaël Townshend, Raphaël John Lamarre Townshend, Raphael J.L. Townshend
Raphael Townshend is a machine-learning researcher turned founder whose work applies geometric deep learning to RNA structure and drug discovery. He holds a BS in electrical engineering and computer science from UC Berkeley, completed a computer science PhD at Stanford in 2021 under Ron Dror, and held positions at DeepMind and Google. As first author of the ATOM3D benchmark suite, which received a Datasets and Benchmarks Award at NeurIPS 2021, and as a co-lead author of the August 2021 Science paper that introduced ARES, a scoring function trained on only 18 known RNA structures, he became a recognized voice in 3D molecular learning. He started Atomic AI in 2021, announced its $35 million Series A in January 2023, and was named to the Forbes 30 Under 30 Science list for 2023. He is founder and CEO of Atomic AI in San Francisco, which designs foundation models for RNA.
- Now at
- Atomic AI
- Badges
Timeline
-
2020–2021
The ATOM3D benchmark suite
In December 2020, he posts ATOM3D as first author, with twelve coauthors including Russ Altman, Risi Kondor and Ron Dror: benchmark datasets spanning several key classes of biomolecules, released with an open-source atom3d Python package. The paper appears in the NeurIPS 2021 Datasets and Benchmarks Track and receives a Datasets and Benchmarks Award at NeurIPS 2021.
-
2021
A Stanford PhD under Ron Dror
He completes a PhD in computer science at Stanford in 2021, advised by Ron Dror in the Stanford AI Lab, with a thesis titled "Geometric learning of biomolecular structure". He earns a BS in electrical engineering and computer science at UC Berkeley, and during the PhD he holds positions at DeepMind and Google.
-
August 2021
The ARES paper in Science
In August 2021, Science publishes "Geometric deep learning of RNA structure", on which he is a co-lead author with Stephan Eismann and Andrew Watkins, in collaboration with Rhiju Das's laboratory at Stanford. Its scoring function ARES, trained on only 18 known RNA structures, outperforms previous methods in community-wide blind RNA structure prediction challenges.
-
2021–2023
Founding Atomic AI
He chooses in 2021 to start a company, Atomic AI, and it raises a $7 million seed round in 2022. In January 2023, the company announces a $35 million Series A led by Playground Global. Its PARSE platform, short for Platform for AI-driven RNA Structure Exploration, extends the models from the Science paper with data the company generates in its own wet labs.
-
2023
Forbes 30 Under 30 in Science
Forbes names him to its 2023 30 Under 30 Science list, describing a founder who combines the RNA revolution behind therapies such as the Covid-19 vaccines with the revolution in predictive protein folding using machine learning.
-
December 2023
A model built on chemical mapping
In December 2023, Atomic AI announces a large language model built with chemical mapping data to optimize RNA therapeutic development. In an August 2024 interview on the Eye on AI podcast, he describes the company's core model, ATOM-1, as designed to predict RNA shapes and so enable drugs that target RNA.
-
As of October 2026
Founder and CEO of Atomic AI
He is founder and CEO of Atomic AI in San Francisco, a company focused on designing foundation models for RNA. Ron Dror, his Stanford PhD advisor, is one of its scientific advisors.
Career
- Since 2021Atomic AIFounder and CEO
Education
Sources and credits
Photo: We have no published photo of Raphael Townshend yet. Send us a free-licensed photo.
- [2012.04035] ATOM3D: Tasks On Molecules in Three Dimensions
- NeurIPS 2021 Awards
- Geometric learning of biomolecular structure | Stanford Digital Repository
- Raphael Townshend, PhD - Biocom
- Raphael Townshend - BIO International Convention | BIO
- Raphael Townshend | Stanford NIH Biotechnology Training Program
- An algorithm predicts biological structures more accurately than ever | Stanford University School of Engineering
- RNA Structures Predicted with Uncanny Accuracy by Unbiased AI
- Atomic AI: Unlocking RNA
- With new funding, Atomic AI envisions RNA as the next frontier in drug discovery | TechCrunch
- Raphael Townshend - Forbes
- News – Atomic AI
- Eye On A.I.: #202 Raphael Townshend: How AI and RNA Tech is Transforming Drug Discovery (Inside Atomic AI)
- About Us – Atomic AI
- Raphael Townshend · Deep Tech Week
